NCT05458609View on ClinicalTrials.gov

Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep

PHASE3CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

February 9, 2023

Primary Completion Date

January 30, 2024

Study Completion Date

January 30, 2024

Conditions

Alcohol Use Disorder

Interventions

DRUG

Lemborexant 10 mg

10 mg of Lemborexant

DRUG

Naltrexone

50 mg of Naltrexone

Trial Locations (1)

77035

The Menninger Clinic, Houston

All Listed Sponsors

lead

Baylor College of Medicine

OTHER